OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells
Ji Hoon Jung, Tae‐Rin Kwon, Soo‐Jin Jeong, et al.
Evidence-based Complementary and Alternative Medicine (2013) Vol. 2013, pp. 1-10
Open Access | Times Cited: 44
Ji Hoon Jung, Tae‐Rin Kwon, Soo‐Jin Jeong, et al.
Evidence-based Complementary and Alternative Medicine (2013) Vol. 2013, pp. 1-10
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 446
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 446
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Ailian Xiong, Zhengduo Yang, Yi‐Cheng Shen, et al.
Cancers (2014) Vol. 6, Iss. 2, pp. 926-957
Open Access | Times Cited: 267
Ailian Xiong, Zhengduo Yang, Yi‐Cheng Shen, et al.
Cancers (2014) Vol. 6, Iss. 2, pp. 926-957
Open Access | Times Cited: 267
Caspase-9 as a therapeutic target for treating cancer
Bonglee Kim, Sanjay Srivastava, Sung‐Hoon Kim
Expert Opinion on Therapeutic Targets (2014) Vol. 19, Iss. 1, pp. 113-127
Closed Access | Times Cited: 142
Bonglee Kim, Sanjay Srivastava, Sung‐Hoon Kim
Expert Opinion on Therapeutic Targets (2014) Vol. 19, Iss. 1, pp. 113-127
Closed Access | Times Cited: 142
Cryptotanshinone: A review of its pharmacology activities and molecular mechanisms
Yanhong Wu, Yu-Rui Wu, Bo Li, et al.
Fitoterapia (2020) Vol. 145, pp. 104633-104633
Closed Access | Times Cited: 83
Yanhong Wu, Yu-Rui Wu, Bo Li, et al.
Fitoterapia (2020) Vol. 145, pp. 104633-104633
Closed Access | Times Cited: 83
Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
Wenfeng Zhang, Cun Liu, Jie Li, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 01, pp. 209-239
Closed Access | Times Cited: 52
Wenfeng Zhang, Cun Liu, Jie Li, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 01, pp. 209-239
Closed Access | Times Cited: 52
Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan
Te‐Hsin Chao, Pin‐Kuei Fu, Chiung‐Hung Chang, et al.
Journal of Ethnopharmacology (2014) Vol. 155, Iss. 1, pp. 702-708
Closed Access | Times Cited: 75
Te‐Hsin Chao, Pin‐Kuei Fu, Chiung‐Hung Chang, et al.
Journal of Ethnopharmacology (2014) Vol. 155, Iss. 1, pp. 702-708
Closed Access | Times Cited: 75
Stimulation of Eryptosis by Cryptotanshinone
Rosi Bissinger, Adrian Lupescu, Christine Zelenak, et al.
Cellular Physiology and Biochemistry (2014) Vol. 34, Iss. 2, pp. 432-442
Open Access | Times Cited: 73
Rosi Bissinger, Adrian Lupescu, Christine Zelenak, et al.
Cellular Physiology and Biochemistry (2014) Vol. 34, Iss. 2, pp. 432-442
Open Access | Times Cited: 73
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
Hu Li, Pengbo Hu, Yajun Zou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Hu Li, Pengbo Hu, Yajun Zou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Targeting Sh2 Domains in Breast Cancer
Pietro Morlacchi, Fredika M. Robertson, Jim Klostergaard, et al.
Future Medicinal Chemistry (2014) Vol. 6, Iss. 17, pp. 1909-1926
Open Access | Times Cited: 63
Pietro Morlacchi, Fredika M. Robertson, Jim Klostergaard, et al.
Future Medicinal Chemistry (2014) Vol. 6, Iss. 17, pp. 1909-1926
Open Access | Times Cited: 63
Multiple pro-apoptotic targets of abietane diterpenoids from Salvia species
Maryam Akaberi, Soghra Mehri, Mehrdad Iranshahi
Fitoterapia (2014) Vol. 100, pp. 118-132
Closed Access | Times Cited: 63
Maryam Akaberi, Soghra Mehri, Mehrdad Iranshahi
Fitoterapia (2014) Vol. 100, pp. 118-132
Closed Access | Times Cited: 63
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo
Li Shen, Zhang Guangshun, Zhaohuan Lou, et al.
BMC Complementary and Alternative Medicine (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 52
Li Shen, Zhang Guangshun, Zhaohuan Lou, et al.
BMC Complementary and Alternative Medicine (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 52
A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4322-4322
Open Access | Times Cited: 37
Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4322-4322
Open Access | Times Cited: 37
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway
Ying Wang, Hui-lan Lu, Yong-dong Liu, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 95, pp. 1388-1396
Closed Access | Times Cited: 45
Ying Wang, Hui-lan Lu, Yong-dong Liu, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 95, pp. 1388-1396
Closed Access | Times Cited: 45
The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
Deok-Beom Jung, Miyong Yun, Eun-Ok Kim, et al.
Oncotarget (2014) Vol. 6, Iss. 7, pp. 4992-5004
Open Access | Times Cited: 43
Deok-Beom Jung, Miyong Yun, Eun-Ok Kim, et al.
Oncotarget (2014) Vol. 6, Iss. 7, pp. 4992-5004
Open Access | Times Cited: 43
Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
Yangqiu Bai, Lida Zhang, Xinhui Fang, et al.
Experimental and Therapeutic Medicine (2016) Vol. 11, Iss. 3, pp. 1085-1089
Open Access | Times Cited: 32
Yangqiu Bai, Lida Zhang, Xinhui Fang, et al.
Experimental and Therapeutic Medicine (2016) Vol. 11, Iss. 3, pp. 1085-1089
Open Access | Times Cited: 32
Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction
Eun Ok Kim, Shi Eun Kang, Chang Rak Im, et al.
International Journal of Oncology (2016) Vol. 48, Iss. 5, pp. 2205-2212
Open Access | Times Cited: 32
Eun Ok Kim, Shi Eun Kang, Chang Rak Im, et al.
International Journal of Oncology (2016) Vol. 48, Iss. 5, pp. 2205-2212
Open Access | Times Cited: 32
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy
Syed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 907-922
Closed Access | Times Cited: 10
Syed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 907-922
Closed Access | Times Cited: 10
The efficacy and safety of pH‐responsive and photothermal‐sensitive multifunctional nanoparticles loaded with cryptotanshinone for the treatment of gastric cancer
Dan Wu, M Chen, Nan Zheng, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 12, pp. 2346-2362
Closed Access | Times Cited: 3
Dan Wu, M Chen, Nan Zheng, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 12, pp. 2346-2362
Closed Access | Times Cited: 3
The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats
Chao Wang, Xiaoling Du, Rui Yang, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2014) Vol. 145, pp. 28-37
Closed Access | Times Cited: 34
Chao Wang, Xiaoling Du, Rui Yang, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2014) Vol. 145, pp. 28-37
Closed Access | Times Cited: 34
Roles of STAT3 in leukemia (Review)
Shi Yin, Zhen Zhang, Xintao Qu, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 26
Shi Yin, Zhen Zhang, Xintao Qu, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 26
Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway
Yonghong Man, Le Yang, Dongxian Zhang, et al.
Oncology Letters (2016) Vol. 12, Iss. 5, pp. 4094-4098
Open Access | Times Cited: 24
Yonghong Man, Le Yang, Dongxian Zhang, et al.
Oncology Letters (2016) Vol. 12, Iss. 5, pp. 4094-4098
Open Access | Times Cited: 24
The anticancer mechanism investigation of Tanshinone IIA by pharmacological clustering in protein network
Yanfeng Cao, Shifeng Wang, Xi Li, et al.
BMC Systems Biology (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Yanfeng Cao, Shifeng Wang, Xi Li, et al.
BMC Systems Biology (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia
Dominique Perez, Yelena Smagley, Matthew Garcia, et al.
Oncotarget (2016) Vol. 7, Iss. 23, pp. 33960-33982
Open Access | Times Cited: 20
Dominique Perez, Yelena Smagley, Matthew Garcia, et al.
Oncotarget (2016) Vol. 7, Iss. 23, pp. 33960-33982
Open Access | Times Cited: 20
Synergistic combinations of tanshinone IIA and trans-resveratrol toward cisplatin-comparable cytotoxicity in HepG2 human hepatocellular carcinoma cells.
Tung-Wu Chang, Chueh-Yu Lin, Yin‐Jeh Tzeng, et al.
PubMed (2014) Vol. 34, Iss. 10, pp. 5473-80
Closed Access | Times Cited: 21
Tung-Wu Chang, Chueh-Yu Lin, Yin‐Jeh Tzeng, et al.
PubMed (2014) Vol. 34, Iss. 10, pp. 5473-80
Closed Access | Times Cited: 21
Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells
Yuqing Ge, Bo Yang, Xiaofeng Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 3, pp. 730-738
Closed Access | Times Cited: 20
Yuqing Ge, Bo Yang, Xiaofeng Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 3, pp. 730-738
Closed Access | Times Cited: 20
